Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andreeff

Showing results (241-250 of 315) with videos related to

Pageof 32
Sort By:
Gene Therapy|June 1, 1995
Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance geneE G Hanania, S Fu, Z Zu, et al.
Leukemia|October 1, 1996
Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adultsS M Kornblau, V Gandhi, H M Andreeff, et al.
Leukemia|August 22, 2003
Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAILW-S Suh, Y S Kim, A D Schimmer, et al.
The Journal of Clinical Investigation|September 19, 2001
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemiaM Milella, S M Kornblau, Z Estrov, et al.
Blood|April 1, 1980
Heterogeneity of cell lineages in L3 leukemiasB Koziner, R Mertelsmann, M Andreeff, et al.
Blood|November 1, 1995
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseS O'Brien, H Kantarjian, M Keating, et al.
The New England Journal of Medicine|September 9, 1993
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantationS Giralt, S Escudier, H Kantarjian, et al.
Blood|September 1, 1996
Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytesJ Drach, A Gsur, G Hamilton, et al.
British Journal of Haematology|December 24, 1997
Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignanciesV Snell, K Clodi, S Zhao, et al.
British Journal of Haematology|March 22, 2001
Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplificationK Pachmann, S Zhao, T Schenk, et al.
Pageof 32

Showing results (241-250 of 315) with videos related to

Sort By:
Pageof 32
Gene Therapy|June 1, 1995
Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance geneE G Hanania, S Fu, Z Zu, et al.
Leukemia|October 1, 1996
Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adultsS M Kornblau, V Gandhi, H M Andreeff, et al.
Leukemia|August 22, 2003
Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAILW-S Suh, Y S Kim, A D Schimmer, et al.
The Journal of Clinical Investigation|September 19, 2001
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemiaM Milella, S M Kornblau, Z Estrov, et al.
Blood|April 1, 1980
Heterogeneity of cell lineages in L3 leukemiasB Koziner, R Mertelsmann, M Andreeff, et al.
Blood|November 1, 1995
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phaseS O'Brien, H Kantarjian, M Keating, et al.
The New England Journal of Medicine|September 9, 1993
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantationS Giralt, S Escudier, H Kantarjian, et al.
Blood|September 1, 1996
Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytesJ Drach, A Gsur, G Hamilton, et al.
British Journal of Haematology|December 24, 1997
Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignanciesV Snell, K Clodi, S Zhao, et al.
British Journal of Haematology|March 22, 2001
Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplificationK Pachmann, S Zhao, T Schenk, et al.
Pageof 32